HIGHLIGHTS
- who: Ryszard Skiba et al. from the Department of General, Functional and Oncological Urology, Military Institute of Medicine, Warsaw, Poland have published the paper: Testosterone Replacement Therapy in Chronic Kidney Disease Patients, in the Journal: Nutrients 2022, 3444 of /2022/
- what: The aim of the study was to evaluate the efficacy and safety of testosterone replacement therapy (TRT) in men with chronic kidney disease and hypogonadism on conservative and hemodialysis treatment.
- how: The authors used the immunochemical method of total testosterone (TT) detection. The influence of androgen therapy on body composition in CKD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.